AGOMAB THERAPEUTICS NV

AGMBNASDAQ

🏆 #2170 by market capEarnings Mar 3US Equity

$674.28▼ $40.05 (−5.94%)

Simulated price

1h—

24h▼ 5.9%

7d—

14d—

30d—

1y—

🏦Market Cap

$853M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

47

Weak

Earnings

Q3 · 2026Reported 2026-08-06

Earnings Per Share

Actual

-0.91

Expected

-0.38

miss

−137.60%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q3 2026

-0.91

miss

Q2 2026

-0.45

miss

Q1 2026

-0.36

beat